It all depends on the deal, doesn't it? For example, if say there is an upfront fee of US$200m, and so on, it would immediately dispel any talk of cap raise. That would kill off quite a few downrampers arguments here.
In addition, besides B cell, the other trials are progressing well. Should results from any of them be spectacular when released in 2025, well...that will see you thru till the next agm for sure. People might even vote happily for even bigger bonuses for Team IMU
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.002(18.2%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.1¢ | $625.7K | 50.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 5795292 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3258567 | 9 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |